French Bulldog BOAS Treatment: $3,500 Surgery vs. Experimental Injectable — Why $85/Month Pet Insurance Often Doesn't Cover What Your Frenchie Actually Needs

You're Holding a French Bulldog Puppy — Let's Look at the Airway Math Before You Sign the Deposit Check

You're holding a French Bulldog puppy. The snorty little face is doing exactly what it was always going to do — you're already in love. Before you hand over the deposit, let's look at something the breeder probably won't bring up: the airway math.

More than half of French Bulldogs develop clinically significant Brachycephalic Obstructive Airway Syndrome (BOAS) at some point in their lives. Until recently, the treatment path was surgical and expensive: $1,800–$6,500 depending on the technique and whether you end up at a specialist. But a new clinical development flagged in DVM360's weekly veterinary report is worth understanding — an experimental injectable BOAS therapy is showing early promise in trials. That changes the conversation. It also changes the financial planning math, which is exactly why we're running these numbers now instead of in a waiting room at 11 PM.

---

What BOAS Surgery Actually Costs in 2026

BOAS surgery addresses the structural anatomy that makes breathing difficult: stenotic nares (narrowed nostrils), an elongated soft palate, and in more severe cases, everted laryngeal saccules. Surgery is typically recommended when dogs show persistent symptoms — noisy labored breathing, exercise intolerance, sleep-disordered breathing, or bluish gums during exertion.

Here's what the procedure costs nationally, based on published AVMA veterinary fee data and specialty clinic schedules:

Procedure	General Practice	Veterinary Specialist
Nares widening only	$400–$900	$800–$1,500
Soft palate resection only	$1,200–$2,500	$2,000–$4,000
Combined traditional BOAS correction	$1,800–$3,500	$3,000–$5,500
Laser-assisted BOAS correction	$3,500–$5,000	$5,000–$8,000
Post-op monitoring and follow-up visits	$300–$700	$500–$1,200

Laser-assisted correction has become increasingly common at specialty centers because it reduces intraoperative bleeding and shortens recovery time — but it adds $2,000–$3,000 over traditional cold-knife technique. We covered that cost comparison in depth in French Bulldog BOAS Surgery: $3,500 Traditional vs. $6,500 Laser — The Pet Insurance Break-Even Math.

---

The Injectable Therapy That's Changing the Conversation (But Isn't Available Yet)

DVM360's weekly vet report flagged an important development: an experimental injectable BOAS therapy targeting the soft tissue dynamics that contribute to airway obstruction is showing early promise in clinical trials. Rather than physically removing or reshaping tissue, the injectable approach appears to modulate the functional tension and inflammatory response in the airway.

What this plausibly means for costs if the therapy advances:

• Non-surgical intervention for mild-to-moderate BOAS cases may become viable
• Injectable therapies at specialty rates typically run $200–$600 per treatment session, likely requiring repeat dosing
• For French Bulldogs currently in a "watch and wait" phase before surgical intervention, this could represent a meaningful — and significantly cheaper — middle path

What this does not mean right now: this is not a proven treatment. It is not available at your vet's office. If your French Bulldog is already showing respiratory distress, do not delay consultation with a veterinary internist or boarded surgeon waiting for a therapy that is still in trials. The peer-reviewed literature is clear that early surgical correction, before secondary damage such as laryngeal collapse or cardiac strain develops, produces consistently better outcomes.

From a financial planning perspective, though, the emergence of a potential non-surgical alternative matters. It may eventually lower the cost of first-line BOAS intervention, reduce the frequency of expensive surgical claims, and — critically — create a new category of insurable event that pet insurance policies treat differently than surgery.

---

Why Pet Insurance Gets Complicated for French Bulldogs

Here's the number that tends to shock new Frenchie owners: most pet insurance policies either exclude or heavily restrict BOAS coverage, classifying it as a hereditary or congenital condition.

This creates a specific trap:

• You buy the policy when your 8-week-old puppy looks completely healthy
• Clinical BOAS symptoms develop at age 1–3 (typical onset range for the breed)
• You submit the surgery claim
• The insurer denies it as a hereditary exclusion

Some policies do cover BOAS if you enroll before any symptoms are documented and the policy explicitly does not exclude hereditary conditions. But the phrase "some policies" is carrying enormous weight there. You need to read the specific exclusion language — not the marketing summary — before you commit to any plan. We walked through exactly how that denial math plays out in What Pet Insurance Actually Reimburses on a $4,500 Emergency Vet Bill, where deductibles, co-pays, and sub-limit clauses interact with hereditary condition claims in ways that rarely match the headline coverage percentage.

This is the kind of policy-level analysis Brevanti runs for you automatically — surfacing which plans actually cover hereditary conditions for brachycephalic breeds instead of leaving you to parse policy contract language yourself.

---

The Insurance Math: A Worked Example

Let's run actual numbers for a French Bulldog owner comparing insurance against self-insuring.

Scenario: 2-year-old French Bulldog, purchased from a reputable breeder, early BOAS symptoms emerging.

Insurance route (policy that covers hereditary conditions):

• Monthly premium for a French Bulldog on an accident-and-illness plan with hereditary coverage: approximately $95–$115/month
• Using $100/month as a round figure
• Annual premium: $1,200
• Over a 10-year expected lifespan: $12,000 in total premiums
• Annual deductible: $250
• Reimbursement rate: 80%

If the dog requires combined BOAS surgery at $4,500 (mid-range specialist cost) in year 3:

• You pay: $250 deductible + 20% of $4,250 = $250 + $850 = $1,100 out of pocket
• Insurance pays: $3,400
• Premiums paid through year 3 before surgery: $3,600
• Net position at surgery: roughly break-even

That looks reasonable — until you factor in the ongoing costs that don't go away after one surgery. French Bulldogs average $700–$1,400 per year in dental cleanings (teeth crowd badly in a compressed jaw, as we cover in detail in French Bulldog Dental Cleaning Costs $700–$1,400: Anesthesia Risk and the Medetomidine Shortage), plus $300–$700 annually in skin fold dermatitis management and $400–$900 per emergency visit. These are chronic, recurring claims — not one-time events.

Lifetime claim projection (conservative, 10 years):

Cost Category	Annual Estimate	10-Year Total
BOAS surgery	$4,500 (once)	$4,500
Dental cleanings	$900/year avg	$9,000
Skin fold dermatitis	$400/year	$4,000
Emergency visits	$600/year avg	$6,000
Other illness/injury	—	$3,000
Total		$26,500

With insurance at 80% reimbursement after deductibles, expected out-of-pocket on covered claims: approximately $6,300. Add the $12,000 in premiums over 10 years: total cost with insurance ≈ $18,300.

Self-insuring: $26,500 out-of-pocket, but you keep the $12,000 you didn't pay in premiums. If you actually put $100/month into a dedicated pet savings account earning 4% annually, that fund grows to roughly $14,700 over 10 years — net cost of self-insuring when claims land: approximately $11,800.

The honest verdict: Self-insuring wins on paper if you're disciplined about the savings account. Insurance wins if a hereditary-inclusive policy is available for your dog's age, you have a low risk tolerance for large one-time bills, and the policy actually covers BOAS. The break-even point is around year 4–5 for most scenarios. What kills the insurance math is paying premiums for years into a policy that denies your biggest claim category at submission.

You can model this for your dog's specific age, zip code, and health history at Brevanti — including which policies in your state actually include BOAS coverage.

---

What the New Feline Hypertension Drug Means for Cat Owners

The same DVM360 report flagged the FDA's approval of a first-of-its-kind dedicated feline hypertension drug — and this is more consequential than it might initially appear.

Feline hypertension is overwhelmingly secondary to chronic kidney disease and hyperthyroidism, two of the most common conditions in cats over age 10. Until now, vets managed it with human-approved amlodipine used off-label — it worked, but lacked feline-specific dosing data. A dedicated feline approval means better-studied protocols and, eventually, a branded product with potentially higher cost than compounded alternatives.

Projected annual treatment costs:

• Off-label compounded amlodipine: $25–$60/month ($300–$720/year)
• New FDA-approved drug: pricing still rolling out, estimated $60–$150/month ($720–$1,800/year)
• Annual monitoring (blood pressure checks, bloodwork): $300–$600/year
• Over a 4-year treatment course (typical for a cat diagnosed at age 12): $4,000–$9,600 in total management costs

This is the category where cat insurance frequently does break even — chronic disease management costs accumulate steadily over years and are predictable enough to model. We covered that math for Maine Coon and domestic shorthair owners in Maine Coon vs. Shelter Cat: Why Annual Vet Bills Run $2,800 vs. $1,100.

---

Indoor Ticks Now Survive Longer Than Anyone Thought — What That Means for Your Prevention Budget

A separate DVM360 research roundup highlighted a study finding that ticks survive significantly longer inside homes under typical indoor conditions — humidity, carpet fibers, moderate temperature — than previously understood. Weeks, not days.

Old assumption: Tick exposure is primarily an outdoor seasonal risk.
Updated data: Ticks hitching a ride indoors on pets or clothing can establish a survival foothold long enough to create household exposure risk across more months of the year.

For breeds already on year-round prevention — Labradors, Beagles, Golden Retrievers, hunting and field breeds — this confirms the existing math. For suburban owners who were treating tick prevention as a summer-only line item, the calculus just shifted.

The break-even on prevention:

• Year-round oral isoxazoline prevention: $120–$360/year depending on dog size
• Lyme disease treatment if prevention fails: $800–$2,500 per episode
• One prevented Lyme episode pays for 3–20 years of prevention, depending on cost tier

We modeled the full prevention-vs-treatment math for Labs, Beagles, and Golden Retrievers — three of the highest tick-exposure breeds — in Dog Lyme Disease Treatment Runs $800–$2,500: New Indoor Tick Research Is Changing the Pet Insurance Break-Even Math.

---

The Through-Line: Your Pet Budget From Two Years Ago Is Already Wrong

Three separate developments from one week of veterinary news — a BOAS injectable in trials, an FDA-approved feline hypertension drug, indoor tick survival data — all shift cost calculations that most pet owners set once and never revisit.

The owners who don't get blindsided by a $5,000 surgery bill aren't necessarily richer. They're the ones who ran the breed-specific numbers before the symptoms appeared, read the policy exclusions before they mattered, and adjusted their prevention spending when the evidence changed.

For French Bulldog owners specifically: the pet is worth it. The financial commitment is real. BOAS affects the majority of the breed, dental costs are chronic and non-negotiable, and the right insurance policy — one that actually covers hereditary conditions — runs $85–$115/month and requires careful vetting of the contract language.

Run your specific numbers — your dog's breed, age, and health history, your local vet cost tier, and the actual policies available in your state — at Brevanti. The math for your situation is different from the math in this post. That's exactly the point.

Sources

• Weekly Vet Report: FDA approves feline hypertension drug, injectable BOAS therapy shows early promise, and more — DVM360
• Purdue University celebrates 5 veterinary medicine alumni — DVM360
• Spirit Airlines Has Shut Down: Here’s What to Do — NerdWallet Insurance
• Wrap up: Study finds ticks could survive longer in homes than previously thought, and other news. — DVM360
• Flex Forecast: May/June 2026 — DVM360